Louise Provencher
Hôpital du Saint-Sacrement(CA)
Publications by Year
Research Areas
Breast Cancer Treatment Studies, Cancer Treatment and Pharmacology, HER2/EGFR in Cancer Research, Advanced Breast Cancer Therapies, Breast Lesions and Carcinomas
Most-Cited Works
- → Adjuvant Docetaxel for Node-Positive Breast Cancer(2005)951 cited
- → Phase III Study of Bevacizumab Plus Docetaxel Compared With Placebo Plus Docetaxel for the First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer(2010)882 cited
- → Sentinel Node Biopsy After Neoadjuvant Chemotherapy in Biopsy-Proven Node-Positive Breast Cancer: The SN FNAC Study(2014)823 cited
- → Everolimus plus exemestane for hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: overall survival results from BOLERO-2(2014)563 cited
- → Chemotherapy‐induced alopecia and effects on quality of life among women with breast cancer: a literature review(2007)413 cited
- → NSABP B-47/NRG Oncology Phase III Randomized Trial Comparing Adjuvant Chemotherapy With or Without Trastuzumab in High-Risk Invasive Breast Cancer Negative for HER2 by FISH and With IHC 1+ or 2+(2019)410 cited
- → Zoledronic acid is superior to pamidronate for the treatment of bone metastases in breast carcinoma patients with at least one osteolytic lesion(2003)333 cited
- → Evaluating Survivorship Care Plans: Results of a Randomized, Clinical Trial of Patients With Breast Cancer(2011)319 cited
- → Randomized Phase II Study Evaluating Palbociclib in Addition to Letrozole as Neoadjuvant Therapy in Estrogen Receptor–Positive Early Breast Cancer: PALLET Trial(2018)229 cited
- → Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node-positive breast cancer: 10-year follow-up of the phase 3 randomised BCIRG 001 trial(2012)221 cited